IV Infusion News
Featured & Company News
Infusion Ventures provides specialty Infusion Nursing services for a variety of medical conditions including Crohn’s Disease, Immunotherapy, Hemophilia and Von Willliebrand Disease.
Chronic Disease Specialists Our highly-trained and caring nurses administer infusion of medication via IV in patient’s homes, including but not limited to patients with hemophilia and immunodeficiencies. We take great pride in our clients’ satisfaction with their...
Are you looking for a new nursing job? Infusion Ventures has infusion nursing jobs available throughout most of the New England area. Call us today at (781) 938-7070 to learn more or visit our website at infusionventures.com.
We are actively seeking RNs to infuse patients in their own homes and invite you to reach out to us today. Infusion Ventures is currently hiring licensed RNs to infuse patients in the comfort of their own homes. Our infusion nursing team supports both on demand...
Infusion Ventures nurses are expert at helping patients manage their lives around IVIg infusions in order to optimize their health and improve their quality of life. Reach out today at (781) 938-7070 to learn more.
Our professionals are specialists in IVIg Long Term Therapy IVIg therapy at home requires experienced and specially trained nurses to administer and monitor patients during infusions. Our patients routinely extol the benefits of home IVIg infusions over inconvenient...
Infusion Ventures, Inc. has provided specialty infusion nursing services to children throughout the New England area since 1993. Call us today to learn more – (781) 938-7070
Infusion Ventures are experts in administering infused medication for children. We handle a large caseload of pediatric patients throughout the New England area. Compassionate care for our youngest patients is critical for success and we are well trained to be able to...
Industry News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.